Prepare Your Antibiotic Research for Rapid, Rigorous Review
IJANR welcomes manuscripts that advance antibiotic discovery, resistance mitigation, and stewardship. These instructions help authors present reproducible, clinically meaningful findings that meet ethical, reporting, and data transparency standards expected in antimicrobial research. Clear reporting supports translation of evidence into clinical guidelines and stewardship programs. Consistent structure also improves reviewer efficiency and decision speed, especially for complex antimicrobial datasets.
Submission Essentials
- Structured abstract and clear keywords
- Methods detail for reproducibility
- Ethics approval and consent statements
- Data and code availability notes
- Conflict of interest disclosures
Manuscripts Accepted by IJANR
Manuscript Structure
Organize manuscripts in a standard scientific format: Title page, abstract, keywords, introduction, methods, results, discussion, conclusions, acknowledgements, and references. Provide clear section headings and ensure that methods and outcomes are easy to follow for interdisciplinary readers.
Title Page
Include a concise, informative title, full author names, affiliations, and a corresponding author email. List ORCID iDs if available. Provide a short running title and a statement of author contributions to clarify accountability.
Abstract and Keywords
Use a structured abstract for research articles with background, methods, results, and conclusions. Highlight the antibiotic or resistance focus and the main clinical or translational impact. Provide 4 to 6 keywords that improve discoverability.
Introduction and Methods
State the clinical or scientific problem, prior work, and your study objective. Methods must include experimental design, strains or isolates, controls, statistical analysis, and reagent details for reproducibility. For antimicrobial testing, report standards used and interpretive criteria.
Results and Discussion
Present results clearly with appropriate statistical analysis and confidence intervals. Interpret findings in relation to antimicrobial resistance, clinical impact, or drug development. Discuss limitations and explain how results inform future research or stewardship strategies.
Figures and Tables
Provide high resolution figures with clear legends. Tables should be editable, not embedded as images. For resistance profiles and MIC data, ensure consistent units and define all abbreviations. Use color responsibly and provide figure permissions if needed.
References
Use a consistent citation style and include DOIs where available. Ensure all references are complete and accurate. Cite primary sources for resistance mechanisms, clinical trials, and therapeutic guidance rather than relying on secondary summaries.
Supplementary Material
Supplementary files may include extended datasets, additional methods, code, or protocols. Clearly label files and reference them in the main text. Provide a brief description so readers understand how supplementary content supports the findings.
Ethics and Compliance
Studies involving humans or animals must include ethics committee approval and consent statements. For clinical studies, state trial registration details and adhere to relevant ethical standards. Any use of patient data must be anonymized and justified.
Reporting Guidelines
Use appropriate reporting standards such as CONSORT for clinical trials, PRISMA for systematic reviews, and STROBE for observational studies. Provide checklists when required and explain deviations where necessary.
Data and Code Availability
Include a data availability statement specifying where datasets and code can be accessed. If restrictions apply, explain how qualified researchers can request access. Provide repository links or accession numbers when available.
Conflicts and Funding
Disclose financial relationships, consulting, or industry funding related to antimicrobial products or diagnostics. List all funding sources and grant numbers. Transparent disclosure protects the credibility of antibiotic research.
Before You Submit
Cover Letter
Explain the novelty, relevance to antibiotic research, and how your work advances resistance mitigation or therapeutic innovation.
Authorship Details
Confirm that all listed authors meet authorship criteria and that contribution statements are complete and accurate.
Permissions
Secure permission for reused figures, tables, or datasets and include credit lines where required.
Language Quality
Ensure the manuscript is clear and professional. Language editing is recommended for non native English authors.
File Formats
Submit text in editable formats and provide figures as separate high resolution files with clear legends.
Response Readiness
Be prepared to address reviewer comments with point by point responses and revised manuscripts.
Submission Routes
Submit via ManuscriptZone for full workflow management or use the simple submission form to begin. Both routes reach the same editorial team and peer review process.
Revision Process
When revisions are requested, respond within the timeline provided. Address each reviewer point clearly and highlight manuscript changes to help editors evaluate your response efficiently.
Proofs and Publication
After acceptance, authors review page proofs for accuracy. Corrections should be limited to factual or typographic issues. Articles are published online with a DOI upon final approval.
Post Publication Updates
IJANR follows transparent correction policies. If errors are identified after publication, the editorial office will work with authors to issue corrections or updates as needed.
Antimicrobial Susceptibility Reporting
For MIC or susceptibility studies, report testing standards, breakpoints, and quality control strains. Include full methodological details so other laboratories can reproduce the analyses.
Genomic and Bioinformatic Data
If genomic sequencing or bioinformatics analysis is used, provide accession numbers, pipeline versions, and key parameters. Describe how resistance genes were identified and validated.
Clinical Trial Registration
Clinical trials must be registered in a public registry before enrollment. Include the registration identifier and clarify primary and secondary outcomes.
Systematic Review Standards
Systematic reviews should follow PRISMA guidance, include search strategies, and provide inclusion and exclusion criteria with a flow diagram.
Preprints and Prior Posting
Preprints are permitted if disclosed at submission. Provide the DOI or URL and confirm that the preprint has not been peer reviewed.
AI Tools Disclosure
If AI tools are used for language or analysis, disclose the tool and its role in the manuscript. Authors remain responsible for accuracy and originality.
Patient Privacy
Remove identifying information from clinical data and images unless explicit consent for publication is obtained and documented.
Correspondence and Appeals
For questions or appeals, contact the editorial office with a clear explanation of concerns and supporting evidence.
Statistical Reporting
Report statistical methods in detail, including software, tests used, and assumptions. Provide confidence intervals and effect sizes where appropriate.
Images and Ethics
Image manipulation is not permitted beyond standard adjustments applied equally across the image. Describe any adjustments and provide raw data on request.
Protocol Availability
When possible, share protocols through repositories or supplementary files to support reproducibility and allow replication across laboratories.
Correspondence and Commentary
IJANR accepts brief correspondence on published work when it adds substantive scientific insight. Include evidence based critique and references.
Drug Nomenclature
Use generic drug names and define abbreviations at first use. For new compounds, provide clear identifiers and references to prior reports.
Units and Concentrations
Report concentrations and doses with standard units. Include dilution ranges and interpretive criteria when presenting susceptibility data.
Isolate and Strain Tables
Provide tables describing isolates, sources, and resistance profiles. Clear metadata supports comparisons across studies.
Checklist Submission
Attach any reporting checklists requested by editors. This helps reviewers verify compliance with study standards.
Statistical Review Readiness
Include sufficient detail for statistical review, including sample size justification and handling of missing data.
Abbreviation List
If multiple abbreviations are used, provide a brief list to improve readability for interdisciplinary readers.
Graphical Abstracts
Graphical abstracts are optional but encouraged for complex antimicrobial studies. Provide a clear visual summary that reflects key results without exaggeration.
Supplementary Figures
Use supplementary figures to present extended datasets or validation experiments. Label files clearly and cite them in the main text.
Supplementary Tables
Use supplementary tables for large resistance datasets or detailed reagent lists to keep the main text focused.
Graph Standards
Ensure axes, units, and statistical annotations are clearly labeled. Avoid visual exaggeration of effects.
Methods Reproducibility
Describe reagents, equipment, and protocols in sufficient detail to allow replication across laboratories.
Study Limitations
Clearly state limitations and potential sources of bias so readers can interpret results appropriately.
Clear, reproducible reporting is essential in antimicrobial research. These guidelines help ensure your work can inform clinical practice, drug development, and public health decisions worldwide.
Submit Your Manuscript
Use ManuscriptZone for complete submission management or choose the simple submission form to start quickly. Ensure file sizes are reasonable for smooth upload and clear review by editors as needed. For questions, contact [email protected] and include your article type and topic area. We are happy to clarify formatting or policy questions. Provide a brief summary to help us respond quickly and route your question efficiently, especially for complex submissions. Include the corresponding author's ORCID if available and applicable.
